Combination therapy with radiation and PARP inhibition enhances responsiveness to anti-PD-1 therapy in colorectal tumor models.

PURPOSE: The majority of colorectal cancers are resistant to cancer immune-checkpoint inhibitors. Ionizing radiation (IR) and several radiosensitizers, including PARP inhibitors, can enhance responsiveness to immune checkpoint inhibitors by potentially complementary mechanisms of action. We assessed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Radiat Oncol Biol Phys
Autors principals: Seyedin, Steven N., Hasibuzzaman, MM, Pham, Vivan, Petronek, Michael S., Callaghan, Cameron, Kalen, Amanda L., Mapuskar, Kranti A, Mott, Sarah L., Spitz, Douglas R., Allen, Bryan G., Caster, Joseph M.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7416439/
https://ncbi.nlm.nih.gov/pubmed/32036006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2020.01.030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars